Fingerprint
Dive into the research topics of 'Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
Research output: Contribution to journal › Article › peer-review
6
Scopus
citations